ArticleEJHaem2026

Sinusoidal Obstruction Syndrome With Inotuzumab Ozogamicin Combined With Ponatinib for Philadelphia-Chromosome-Positive Lymphoblastic Malignancies.

Emi Yokoyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.